...
首页> 外文期刊>Acta Biotechnologica >Formation of aminium lactates in lactic acid fermentation: fermentative production of 1, 4-piperazinium-(L.L)-dilactate and its use as a starting material for the synthesis of dilactide (part 2)
【24h】

Formation of aminium lactates in lactic acid fermentation: fermentative production of 1, 4-piperazinium-(L.L)-dilactate and its use as a starting material for the synthesis of dilactide (part 2)

机译:乳酸发酵中乳酸铵的形成:1,4-哌嗪鎓-(L.L)-乳酸的发酵生产及其作为合成丙交酯的原料(第2部分)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A fermentation process for manufacturing 1, 4-piperazinium-(L,L)-dilactate from renewable raw materials and a method for processing this product into L,L-dilactide are described. Lactic acid fermentation with Lactobacillus paracasei was modified insuch a way that pH control occurred by using an aqueous solution of piperazine as a correcting agent instead of sodium hydroxide solution. The production of a stoichiometrically composed piperazinium lactate was possible when the pH was 5.0. From 5.0 kgof glucose and 2.15 kg of piperazine, 6.65 kg of 1, 4-piperazinium-(L,L-dilactate were formed in the fermentation process. Separation from fermentation broth, purification and concentration of the product in aqueous solutions were carried out by means ofultrafiltration, nanofiltration and electrodialysis. Total product retention by the membranes used was about 33%. The crystalline salt was obtained by vacuum evaporation. Processing of the 1, 4-piperazinium-(L,L)-dilactate into L,L-dilactide was performed in a special glass reactor. A product yield of 70% was achieved. The purified product was characterized by elementary analysis, as well as solubility behaviour, polarity and spectroscopic data. An overall process consisting of the stages fermentation,purification and concentration of piperazinium dilactate as well as cycliazation of the latter to dilactide is described.
机译:描述了由可再生原料制造1,4-哌嗪鎓-(L,L)-乳酸的发酵方法和将该产物加工成L,L-乳酸的方法。修饰副干酪乳杆菌的乳酸发酵,使得通过使用哌嗪水溶液作为校正剂而不是氢氧化钠溶液来控制pH。当pH为5.0时,可以生产化学计量组成的乳酸哌嗪鎓。在发酵过程中,由5.0千克葡萄糖和2.15千克哌嗪形成6.65千克1,4,哌嗪-(L,L-Dilactate),从发酵液中分离,纯化和在水溶液中浓缩产物。用超滤,纳滤和电渗析的方法,所用膜的总产物截留率约为33%,通过真空蒸发得到结晶盐,将1,4-哌嗪鎓-(L,L)-乳酸酯加工成L,L-二乳酸在一个特殊的玻璃反应器中进行,产品收率达到70%,通过元素分析,溶解性,极性和光谱数据对纯化的产物进行了表征,整个过程包括发酵,纯化和浓缩三个阶段。描述了哌嗪二乳酸以及其环化成二乳酸。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号